Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for Interferon-γ

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 6, 1996, Pages 1356-1365

  Durham, Stephen R ^a,c   Ying, Sun ^a   Varney, Veronica A ^a   Jacobson, Mikila R ^a   Sudderick, Robert M ^a   Mackay, Lan S ^a   Kay, A Barry ^a   Hamid, Qutayba A ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cytokine; Eosinophil; Grass pollen immunotherapy; Late nasal response; T lymphocyte

Indexed keywords

ALLERGEN; GAMMA INTERFERON; MESSENGER RNA;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; EOSINOPHIL; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; IN SITU HYBRIDIZATION; LYMPHOCYTIC INFILTRATION; MALE; NOSE MUCOSA; PRIORITY JOURNAL; PROVOCATION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ADULT; ALLERGENS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; MALE; NASAL MUCOSA; NASAL PROVOCATION TESTS; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; RNA, MESSENGER;

EID: 0030003889     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70205-1     Document Type: Article

References (42)

1. Frankland AW, Augustin R. Prophylaxis of summer hayfever and asthma. A controlled trial comparing crude grass-pollen extracts with the isolated main protein component. Lancet 1954;1:1055-7.
2. Bousquet J, Hejjaoui A, Soussana M, Michel F-B. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990;85:490-7.
3. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hayfever uncontrolled by anti-allergic drugs. Br Med J 1991;302:265-9.
4. Anonymous. CSM update. Desensitising vaccines. Br Med J 1986;293:948.
5. Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AK, Hill BM. IgE antibody measurements in ragweed hayfever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest 1973;52:472-82.
6. Djurup R. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen specific immunotherapy. Allergy 1985;40:469-86.
7. Furin MJ, Norman PS, Creticos PS, et al. Immunotherapy decreases antigen-induced eosinophil migration into the nasal cavity. J Allergy Clin Immunol 1991;88:27-32.
8. Iliopoulos O, Proud D, Adkinson NF, et al. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991;87:855-66.
9. Otsuka H, Mezawa A, Ohnishi M, Okubo K, Sehi H, Okuda M. Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy 1991;21:115-20.
10. Creticos PS, Adkinson NF Jr, Kagey-Sobotka A, et al. Nasal challenge with ragweed in hayfever patients: effect of immunotherapy. J Clin Invest 1985;76:2247-53.
11. Parker WA, Whisman BA, Apaliski SJ, Reid MJ. The relationships between cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84:667-77.
12. Pienkowski MM, Norman PS, Lichtenstein LM. Suppression of late-phase skin reactions by immunotherapy with ragweed extract. J Allergy Clin Immunol 1985;76:729-34.
13. Warner JO, Price JF, Soothill JF, Hey EN. Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978;2:912-5.
14. Van Bever HP, Stevens WJ. Suppression of the late asthmatic reaction by hyposensitisation in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus). Clin Exp Allergy 1989;19:399-404.
15. Varney VA, Jacobson MR, Sudderick RM, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils and neutrophils. Am Rev Respir Dis 1992;146:170-6.
16. Durham SR, Sun Ying, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and GM-CSF in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
17. Pene J, Rousset R, Briere F, et al. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFNγ. J Immunol 1988;141:1218-24.
18. Varney VA, Hamid QA, Gaga M, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
19. Fokkens WJ, Vroom TM, Gerritsma V, Rijntjes E. A biopsy method to obtain high quality specimens of nasal mucosa. Rhinology 1988;26:293-5.
20. Moqbel R, Barkans J, Bradley BL, Durham SR, Kay AB. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin Exp Allergy 1992;22:265-73.
21. Sun Ying, Durham SR, Jacobson M, et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993;9:356-60.
22. Sun Ying, Durham SR, Jacobson MR, et al. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:200-6.
23. Mayer S, Knebel M, Bayer C. Evaluation of in vitro histamine release from whole blood during immunotherapy of children with insect sting allergy [Abstract]. J Allergy Clin Immunol 1993;91:284.
24. Kuna P, Alan R, Kuzminska B, Rozniecki J. The effect of preseasonal immunotherapy on the production of histamine releasing factor (HRF) by mononuclear cells from patients with seasonal rhinitis: results of a double-blind placebo-controlled, randomized study. J Allergy Clin Immunol 1989;83:816-24.
25. Rocklin RE, Sheffer AL, Greineder DR, Melmon KL. Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med 1980;302:1213-9.
26. Mosmann TR, Cherwinski H, Bond MW, Gieldin MA, Coffman RL. Two types of murine helper T cell clone. J Immunol 1986;136:2348-57.
27. + T lymphocytes in atopic patients. J Immunol 1990;144:4651-6.
28. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992;148:1086-92.
29. Del Prete G, Maggi E, Parronchi P, et al. IL-4 is an essential co-factor for the IgE synthesis induced In vitro by human T cell clones and their supernatants. J Immunol 1988;140:4193-8.
30. Clutterbuck EJ, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 1989;73:1504-12.
31. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara D, Sanderson CJ, Kay AB. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71:258-65.
32. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
33. + T cells from allergic individuals. J Exp Med 1993;178:2123-30.
34. H1 murine helper T lymphocyte clones. J Immunol 1988;140:4245-52.
35. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990;248:1230-4.
36. H2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFNγ. J Immunol 1989;143:15-22.
37. Masuyama K, Jacobson MR, Rak S, et al. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 (IL-4) in the nasal mucosa in allergic rhinitis. Immunology 1994;82:192-9.
38. Brunet C, Bedard P-M, Lavoie A, Jobin M, Hebert J. Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy. J Allergy Clin Immunol 1992;89:87-94.
39. Fanslow WC, Clifford KM, Rubin AS, Voice RF, Beckman MP, Widmer MB. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol 1991;147:535-40.
40. Chand N, Harrison JE, Rooney S, et al. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pig: a therapeutic approach. Eur J Pharmacol 1992;211:121-3.
41. Li JTC, Yunginger JW, Reed CE, Jaffe HS, Nelson DR, Gleich GJ. Lack of suppression of IgE production by recombinant Interferon gamma: a controlled trial in patients with allergic rhinitis. J Allergy Clin Immunol 1990;85:934-40.
42. Herzog C, Walker C, Muller W, et al. Anti-CD4 antibody treatment of patients with rheumatoid arthritis. I. Effect on clinical course and circulating T cells. J Autoimmun 1989;2:627-42.